MDT — Medtronic Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for Medtronic, fiscal year end - April 28th, USD millions except per share, conversion factor applied.

	2019 April 26th	2020 April 24th	2021 April 30th	2022 April 29th	2023 April 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	30,557	28,913	30,117	31,686	31,227
Cost of Revenue
Gross Profit	21,493	19,644	19,762	21,715	20,605
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	24,774	24,535	25,941	25,934	25,795
Operating Profit	5,783	4,378	4,176	5,752	5,432
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,197	4,055	3,895	5,517	5,364
Provision for Income Taxes
Net Income After Taxes	4,662	4,743	3,524	5,061	3,784
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	4,631	4,789	3,606	5,039	3,758
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,631	4,789	3,606	5,039	3,758
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.31	4.13	3.56	4.59	2.94
Dividends per Share